Search

Search Results

• Diagnostic Value of Platelet Transcriptome in Myeloproliferative Neoplasms

  I.A. Olkhovskiy, M.A. Stolyar, A.S. Gorbenko

  131-141

  01.04.2026

• TWIST1 Protein Expression in Plasma Cell Neoplasias and Plasmablastic Lymphoma

  Mariya Vladimirovna Melnikova, A.M. Kovrigina, M.V. Soloveva, Yu.A. Chabaeva, S.M. Kulikov, T.N. Obukhova, B.V. Biderman, I.A. Yakutik, A.B. Sudarikov

  70-80

  01.01.2026

• DNA Methylation Genes in Multiple Myeloma: What We Already Know and How It Can Be Used?

  Daria Aleksandrovna Chebykina, E.V. Motyko, A.N. Kirienko, D.V. Kustova, O.B. Krysiuk, S.V. Sidorkevich, I.S. Martynkevich

  315-325

  01.10.2025

• Myeloid Sarcoma with Skin and Spinal Lesions and KRAS Gene Mutation, Complicated by Secondary Hemophagocytic Syndrome: A Case Report and Literature Review

  Tatyana Nikolaevna Tolstykh, O.L. Kochneva, E.N. Misyurina, E.A. Baryakh, M.A. Mingalimov, K.V. Yatskov, S.A. Kardovskaya, D.D. Ivanova, T.S. Chudnova, D.V. Lebedev, A.N. Titova, E.I. Zhelnova

  242-249

  01.07.2025

• Theoretical and Practical Aspects of Studying the Fractions of BAALC-Expressing Hematopoietic Stem Cells in Acute Myeloid Leukemia Patients with FLT3 Mutations

  Nikolai Nikolaevich Mamaev, M.M. Kanunnikov, A.I. Shakirova, I.M. Barkhatov, A.M. Sadykov, B.I. Ayubova, T.L. Gindina, J.J. Vlasova, S.N. Bondarenko

  73-85

  01.01.2025

• KRAS/NRAS Gene Mutations and the Efficacy of Bortezomib-Based Triplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma

  Anna Mikhailovna Sergeeva, V.L. Surin, Yu.A. Chabaeva, A.A. Kraizman, M.V. Solovev, S.M. Kulikov, L.P. Mendeleeva

  256-265

  01.07.2024

• Cladribine in the Treatment of Multifocal Multisystem Langerhans Cell Histiocytosis in a Patient with a Poor Prognosis. A Case Report

  Vsevolod Gennadevich Potapenko, E.P. Burlachenko, J.-F. Emile, E.V. Zabutova, E.N. Imyanitov, O.V. Nebelitskaia, N.A. Kotova, V.V. Kozyro, I.A. Samorodova, A.V. Serkov, K.A. Skoriukova, E.A. Turkevich, N.V. Medvedeva

  273-279

  01.07.2024

• Ibrutinib in Chronic Lymphocytic Leukemia Therapy for High- and Very-High-Risk Patients over 60 Years of Age

  Nadezhda Viktorovna Kurkina, E.A. Repina, E.I. Gorshenina, V.O. Kurkina, P.V. Volkova, A.A. Repin

  37-42

  17.05.2024

• Treatment Outcomes with Asciminib, the First Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor, in Chronic Myeloid Leukemia Patients with Multiple Resistance to Prior Therapy

  A.G. Turkina, Elena Andreevna Kuzmina

  311-320

  09.06.2023

• The Prognostic Value of Somatic Mutations of Epigenetic Regulation Genes in Acute Myeloid Leukemias in Real-World Clinical Practice: Results of an Observational Non-Interventional Prospective Interregional Study

  Aleksina Alekseevna Shatilova, I.G. Budaeva, A.V. Petukhov, S.A. Silonov, A.E. Ershova, T.S. Nikulina, Yu.D. Matvienko, Yu.V. Mirolyubova, K.V. Bogdanov, L.V. Anchukova, Yu.S. Neredko, S.Yu. Tyasko, O.E. Ochirova, A.G. Karpova, E.R. Vasil’eva, O.D. Serdyuk, D.A. Yaskulskii, D.V. Bukin, Yu.A. Alekseeva, E.G. Lomaia, L.L. Girshova

  174-185

  03.03.2023

• Ibrutinib Efficacy in First-Line Therapy of High-Risk Patients Vs. Second- and Third-Line Therapies of Resistant Chronic Lymphocytic Leukemia

  Nadezhda Viktorovna Kurkina, E.A. Repina, P.V. Volkova, A.A. Repin

  209-212

  03.03.2023

• Identification of Somatic Mutations in EZH2 Gene and Assessment of Their Prognostic Value in Follicular Lymphoma Grades 1–3А

  Ekaterina Sergeevna Nesterova, N.A. Severina, B.V. Biderman, A.B. Sudarikov, A.M. Kovrigina, T.N. Obukhova, Ya.K. Mangasarova, S.M. Kulikov, E.E. Zvonkov, E.N. Parovichnikova, V.G. Savchenko

  80-87

  01.01.2023

• Gilteritinib as a New Option for the Treatment of Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Gene Mutation: A Literature Review and Three Case Reports

  D.V. Motorin, L.L. Girshova, E.G. Lomaia, Yu.A. Alekseeva, A.V. Petukhov, V.V. Ivanov, E.K. Antonov, S.V. Efremova, A.I. Reshetova, E.N. Tochenaya, Aleksina Alekseevna Shatilova, E.N. Tochenaya, A.V. Petrov, T.S. Nikulina, K.V. Bogdanov, D.V. Ryzhkova, Yu.V. Mirolyubova, I.E. Prokop’ev, I.G. Budaeva

  69-79

  01.01.2023

• Ibrutinib as First-Line Therapy in High-Risk Chronic Lymphocytic Leukemia: Case Reports

  Nadezhda Viktorovna Kurkina, E.A. Repina

  488-495

  01.10.2021

• Treatment of Mastocytosis: A Literature Review

  Karina Maksimovna Chernavina, A.S. Orlova, E.A. Nikitin

  361-369

  01.07.2021

• Prognostic Value of Next-Generation Sequencing Data in Patients with Myelodysplastic Syndrome

  Nikolai Yur’evich Tsvetkov, E.V. Morozova, I.M. Barkhatov, I.S. Moiseev, M.V. Barabanshchikova, A.V. Tishkov, D.S. Bug, N.V. Petukhova, E.A. Izmailova, S.N. Bondarenko, B.V. Afanasyev

  170-175

  01.04.2020

• Molecular Diagnosis of FLT3 Mutations in Acute Myeloid Leukemia Patients

  E.K. Zaikova, Ekaterina Vasil’evna Belotserkovskaya, D.V. Zaytsev, A.V. Petukhov, O.A. Fedorova, D.V. Motorin, V.V. Ivanov, A.Yu. Zaritskey, L.L. Girshova

  150-160

  01.04.2020

• TP53 Gene Mutations in Tumor Cells of Patients with Aggressive B-Cell Lymphomas

  Anna Evgen’evna Misyurina, S.K. Kravchenko, V.A. Misyurin, A.M. Kovrigina, A.U. Magomedova, E.A. Baryakh, F.E. Babaeva, A.V. Misyurin

  263-270

  01.07.2019

• WT1 Gene Overexpression in Differential Diagnosis of Ph-negative Myeloproliferative Disorders

  E.G. Lomaia, Nadiya Tamazovna Siordiya, E.G. Lisina, O.M. Senderova, A.A. Silyutina, A.Yu. Zaritskey

  297-302

  01.07.2019

• Prognostic Value of Genetic Mutations in Patients with Acute Myeloid Leukemias: Results of a Cooperative Study of Hematology Clinics of Saint Petersburg (Russia) and Charite Clinic (Germany)

  Ekaterina Vadimovna Motyko, O.V. Blau, L.B. Polushkina, L.S. Martynenko, M.P. Bakai, N.Yu. Tsybakova, Yu.S. Ruzhenkova, E.V. Kleina, N.B. Pavlenko, A.M. Radzhabova, E.V. Karyagina, O.S. Uspenskaya, S.V. Voloshin, A.V. Chechetkin, I.S. Martynkevich

  211-219

  01.04.2019

• Expression of the BCR-ABL1 Gene in Patients with Chronic Myeloproliferative Diseases with Signs of Progression

  L.A. Kesaeva, E.N. Misyurina, D.S. Mar’in, E.I. Zhelnova, A.Yu. Bulanov, A.E. Misyurina, A.A. Krutov, I.N. Soldatova, S.S. Zborovskii, V.A. Misyurin, V.V. Tikhonova, Yu.P. Finashutina, O.N. Solopova, N.A. Lyzhko, A.E. Bespalova, N.N. Kasatkina, A.V. Ponomarev, M.A. Lysenko, Andrei Vital’evich Misyurin

  354-359

  01.10.2018

• Tyrosine Kinase Inhibitor Resistance in Patients with Chronic Myeloid Leukemia: A 10-Year Study of BCR-ABL Gene Mutation Profile in Russia (2006–2016)

  Vera Vyacheslavovna Tikhonova, M.A. Isakov, V.A. Misyurin, Yu.P. Finashutina, L.A. Kesaeva, N.A. Lyzhko, I.N. Soldatova, N.N. Kasatkina, E.N. Misyurina, A.V. Misyurin

  227-233

  01.07.2018

• Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

  Elena L’vovna Nazarova, N.V. Minaeva, M.N. Khorobrykh, E.E. Sukhorukova, V.I. Shardakov, I.V. Paramonov, N.A. Zorina

  54-69

  01.01.2018

• Cytogenetic and Molecular Genetic Prognostic Factors of Acute Lymphoblastic Leukemias

  Andrei Vital’evich Misyurin

  317-323

  01.07.2017

• Molecular Genetic Markers and Clinical Characteristics of Essential Thrombocythemia

  Anastasiya Andreevna Zhernyakova, I.S. Martynkevich, V.A. Shuvaev, L.B. Polushkina, M.S. Fominykh, V.Yu. Udal’eva, I.I. Zotova, D.I. Shikhbabaeva, M.N. Zenina, N.A. Potikhonova, S.V. Voloshin, S.S. Bessmel’tsev, A.V. Chechetkin, K.M. Abdulkadyrov

  402-408

  01.07.2017

• Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia

  Vladimir Vladimirovich Strugov, E.A. Stadnik, A.M. Rumyantsev, T.O. Andreeva, Yu.V. Virts, Yu.V. Mirolyubova, P.A. Butylin, A.Yu. Zaritskey

  141-149

  01.04.2017

• Cytogenetic and Molecular Genetic Prognostic Factors of Acute Myeloid Leukemia

  Andrei Vital’evich Misyurin

  227-234

  01.04.2017

• Genetic Mutations in Acute Myeloid Leukemia

  Ol’ga Vladimirovna Blau

  245-256

  01.07.2016

• Modern Approaches to Diagnosis and Treatment of Essential Thrombocythemia: Literature Review and Own Experience

  K.M. Abdulkadyrov, Vasilii Anatol’evich Shuvaev, I.S. Martynkevich

  235-247

  01.07.2015

• High-Dose Chemotherapy for Grade 3B Relapsed Follicular Lymphoma with Deletions of Loci of BCL6 (3q27) and TP53 (17p13) Genes: Case Report and Literature Review

  E.E. Zvonkov, Nelli Georgievna Gabeeva, M.V. Firsova, E.V. Moiseeva, V.V. Troitskaya, L.A. Kuz’mina, T.N. Obukhova, A.M. Kovrigina, E.N. Parovichnikova, V.G. Savchenko

  36–43

  01.01.2015

• Hematopoietic stem cell transplantation in AML patients with t(8;21)(q22;q22) translocation

  N.N. Mamayev, A.V. Gorbunova, T.L. Gindina, I.M. Barkhatov, S.N. Bondarenko, M.Yu. Averyanova, О.V. Pirogova, O.V. Goloshchapov, Ye.V. Kondakova, B.V. Afanasyev

  439-444

  01.10.2013